Northwestern Mutual Wealth Management
FDMT icon

Northwestern Mutual Wealth Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Buy
+1,094
New +$9.52K ﹤0.01% 3059
2025
Q2 		– Sell
-1
Closed -$3 – 3772
2025
Q1 		$3 Hold
1
– – ﹤0.01% 3636
2024
Q4 		$6 Sell
1
-66
-99% -$518 ﹤0.01% 3562
2024
Q3 		$724 Buy
67
+66
+6,600% +$1.09K ﹤0.01% 3293
2024
Q2 		$21 Hold
1
– – ﹤0.01% 3448
2024
Q1 		$32 Buy
+1
New +$26 ﹤0.01% 3490

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northwestern Mutual Wealth Management's FDMT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in 4D Molecular Therapeutics (FDMT) in Q1 2026: 1,094 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in FDMT as recently as Q1 2025.

Northwestern Mutual Wealth Management first reported a position in FDMT in Q1 2024 and has held it in 6 quarters since. 152 funds tracked by Wall St. Rank hold FDMT as of Q1 2026.

  • Northwestern Mutual Wealth Management held 1,094 shares of 4D Molecular Therapeutics worth $10.2K as of Q1 2026.
  • 4D Molecular Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3059 holding.
  • Northwestern Mutual Wealth Management first reported a position in 4D Molecular Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 152 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.